Differences in Performance on Quality Measures for Thrombectomy-Capable Stroke Centers Compared With Comprehensive Stroke Centers in 2019 to 2020.

Stroke Vasc Interv Neurol · 2022 · PMC12778829 · PMID 41582965

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significanceP =0.09so close (0.05 < p ≤ 0.1)

Proportion of Patients Undergoing MT With Symptomatic Hemorrhage (CSTK‐05b) In 2019, the median proportion of patients undergoing MT who had a symptomatic hemorrhagic complication was 5.3% for CSCs compared with 7.7% for TSCs; this difference did not reach statistical significance (Table 2 ; P =0.09).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.